NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1

NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1

Item
http://www.wikidata.org/entity/Q57675122
Induction of apoptosis of human primary osteoclasts treated with extracts from the medicinal plant Emblica officinalisA comprehensive manually curated reaction map of RANKL/RANK-signaling pathwayThe Regulatory Roles of MicroRNAs in Bone Remodeling and Perspectives as Biomarkers in OsteoporosisElevated Lifetime Lead Exposure Impedes Osteoclast Activity and Produces an Increase in Bone Mass in Adolescent MiceTargeting bone remodeling by isoflavone and 3,3'-diindolylmethane in the context of prostate cancer bone metastasisSH3BP2 cherubism mutation potentiates TNF-α-induced osteoclastogenesis via NFATc1 and TNF-α-mediated inflammatory bone loss.Interactions of the Immune System with Skin and Bone Tissue in Psoriatic Arthritis: A Comprehensive Review.Hexane-Soluble Fraction of the Common Fig, Ficus carica, Inhibits Osteoclast Differentiation in Murine Bone Marrow-Derived Macrophages and RAW 264.7 Cells.Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine.Mitf induction by RANKL is critical for osteoclastogenesis.Activating transcription factor 4 regulates osteoclast differentiation in mice.TRP14 inhibits osteoclast differentiation via its catalytic activityMice Deficient in NF-κB p50 and p52 or RANK Have Defective Growth Plate Formation and Post-natal Dwarfism.Mitf regulates osteoclastogenesis by modulating NFATc1 activity.Water extract of the fruits of Alpinia oxyphylla inhibits osteoclast differentiation and bone loss.MIP-1δ activates NFATc1 and enhances osteoclastogenesis: involvement of both PLCγ2 and NFκB signaling.2-Methoxystypandrone represses RANKL-mediated osteoclastogenesis by down-regulating formation of TRAF6-TAK1 signalling complexesBiology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond.TRAF family member-associated NF-κB activator (TANK) induced by RANKL negatively regulates osteoclasts survival and functionFucoidan, a sulfated polysaccharide, inhibits osteoclast differentiation and function by modulating RANKL signaling.TNF activates calcium-nuclear factor of activated T cells (NFAT)c1 signaling pathways in human macrophages.Subchondral pre-solidified chitosan/blood implants elicit reproducible early osteochondral wound-repair responses including neutrophil and stromal cell chemotaxis, bone resorption and repair, enhanced repair tissue integration and delayed matrix depLactobacillus fermentation enhances the inhibitory effect of Hwangryun-haedok-tang in an ovariectomy-induced bone loss.Water extract of Spatholobus suberectus inhibits osteoclast differentiation and bone resorptionNovel functions for NFκB: inhibition of bone formationTLR2-dependent modulation of osteoclastogenesis by Porphyromonas gingivalis through differential induction of NFATc1 and NF-kappaB.Inhibition of osteoclast differentiation and bone resorption by N-methylpyrrolidone(+)-Vitisin A inhibits osteoclast differentiation by preventing TRAF6 ubiquitination and TRAF6-TAK1 formation to suppress NFATc1 activationHigh-fat diet causes bone loss in young mice by promoting osteoclastogenesis through alteration of the bone marrow environment.NF-κB-Mediated Regulation of OsteoclastogenesisRole of NF-κB in the skeletonMutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bonePositive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritisRhinacanthin C Inhibits Osteoclast Differentiation and Bone Resorption: Roles of TRAF6/TAK1/MAPKs/NF-κB/NFATc1 SignalingStauntonia hexaphylla (Lardizabalaceae) leaf methanol extract inhibits osteoclastogenesis and bone resorption activity via proteasome-mediated degradation of c-Fos protein and suppression of NFATc1 expression.TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 ExpressionHeavy Metal Ion Regulation of Gene Expression: MECHANISMS BY WHICH LEAD INHIBITS OSTEOBLASTIC BONE-FORMING ACTIVITY THROUGH MODULATION OF THE Wnt/β-CATENIN SIGNALING PATHWAY.Adenosine A1 receptor regulates osteoclast formation by altering TRAF6/TAK1 signaling.Effects of Combined Exposure to Lead and High-Fat Diet on Bone Quality in Juvenile Male MiceVitamin E as an Antiosteoporotic Agent via Receptor Activator of Nuclear Factor Kappa-B Ligand Signaling Disruption: Current Evidence and Other Potential Research Areas
P2860
Q21254649-41D68E1A-D81B-4707-83ED-7CF72CF5A1AEQ24599024-8048710B-CFC1-482A-9D52-59AA8A3D50B3Q26748699-F3C430E6-962D-43BF-877D-06F19B3EF0EDQ28396525-BF356F46-3217-4F8E-AE70-3250F1844FF6Q28731449-0B14CF19-9E28-47EC-9756-C945E61EDF30Q30009398-A074FC0D-9628-4027-8AE0-EFD88CC6D95DQ30251957-8906B28A-C866-4369-A200-912276338738Q33574123-2C7ED4AD-D83E-4497-A34F-9937D3665FCBQ33816415-8EF65D52-D26A-4ACE-BD7F-4C9FA53BCEC2Q33848784-1EDB4CDE-464C-44BE-B317-70425123B30FQ34028709-C5578547-FFDC-412A-B3F3-8256F81903F9Q34056632-68A7BAC8-F30A-4DCC-9A27-1F9C28E44994Q34246045-D8D1CAB1-8019-4F72-90C5-5F7108C851DAQ34257775-DBCBC778-671F-4264-BC3F-AD3656FBB14AQ34278522-8AAA4975-1F8D-4F82-9A41-1B4B8D5BA7E6Q34336687-19D9737E-1DCC-46C1-9E59-81CB859168C0Q34339766-0E7C3733-90D0-424C-B547-E99C6453B1A6Q34366449-1FCE8528-7B54-440A-955C-933EE929AC0EQ34471711-1DF41CD0-ED04-40FD-9CCC-88509CCEE3D9Q34486957-B50D9E7E-E726-4867-A9A9-905092C1C69CQ34533668-1813B5DB-2525-4ED6-86E1-ED1026B3DE91Q34550026-25114FD7-F351-4101-942F-5C0B9D0204C1Q34726279-732CEB23-EACA-42B5-9305-14439336E623Q34732774-DE885F00-7272-4303-8A50-2CA86AF40046Q34806538-DD3FB66E-F144-4C91-AC0A-C8F3BBC5CD3FQ35085107-1B40BEDF-DD3C-4664-957B-B9E84289F24CQ35085185-C9E2F197-2267-440F-92E8-F3FD52856483Q35099825-63418C60-F34C-459A-B6D1-FD55BAB3A472Q35247362-C25A3A73-F788-4324-8797-212F9024713AQ35260971-D85A95DF-1308-41E6-BF51-611368989E6CQ35347883-4535FA49-9C95-4045-8B46-D7025BCB7FB1Q35416974-84913C47-6329-4193-99BE-827FEE36057FQ35617594-140B85DC-049C-437F-AC20-88D2C5EBCA86Q35666187-EA4A2BB3-E451-436A-B437-AE748EA67D6BQ35745300-3488E202-DDA2-43F7-A38D-4F6A97747122Q35750113-A1458C38-759C-473C-8ECC-9C6A19035E29Q35859575-79A53430-BEA0-4F24-BE60-0C755A925526Q35953968-0093B162-9A6E-438A-9ACD-67768DBA6894Q36112026-E6AAFF86-5348-413B-8F36-D2B2E3459208Q36165613-4D445E2E-70AF-4A68-BFC2-B3CAA25C6DB9
P2860

NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1

Item
http://www.wikidata.org/entity/Q57675122
description
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
im Mai 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in Journal of Biological Chemistry
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2007
@uk
name
NF-κB p50 and p52 Regulate Rec ...... by Activating c-Fos and NFATc1
@en
NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand
@nl
type
label
NF-κB p50 and p52 Regulate Rec ...... by Activating c-Fos and NFATc1
@en
NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand
@nl
prefLabel
NF-κB p50 and p52 Regulate Rec ...... by Activating c-Fos and NFATc1
@en
NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
NF-κB p50 and p52 Regulate Rec ...... by Activating c-Fos and NFATc1
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698